Smouldering myeloma: detection, risk stratification and defining a new standard of care
Why do charities need to keep funding research into leukemia and blood cancer in general?
Key factors in the tumor-tumor microenvironment relationship in myeloma
MUK Nine b: OPTIMUM, paving the way to effectively treat newly diagnosed high-risk MM
What are the next steps for liposomal chemotherapy delivery and CPX-351?